Clinical Trials
LACOG 0312 - METASTATIC BC
Title
Metastatic cancer in Brazil: characterization of patients and treatments.
Primary Objective
To describe patients demographics and socioeconomic characteristics and to describe the BC pathological characterization.
Design
All patients diagnosed with de novo or recurrent MBC from January 2012 to December 2012 at participating centers will be included. Data will be collected in selected LACOG centers (N=15-20) comprising different regions in Brazil. Availability of tumor samples (FFPE) stored in the center will be registered for a possible future translational research.
Sample size: 500 - 1500
LACOG Study Coordinators: Carlos Barrios, Eduardo Cronemberger, Gustavo Werustky, Jeovany Martinez-Mesa, José Bines, Max Senna Mano, Pedro Liedke, Vanessa Dybal.
Status: Open. Regulatory Process in Brazil.
Sponsor: Novartis.
Registry
Clinicaltrials.gov: NCT02662868
Contact
lacog@lacog.org.br
Phone: 55 51 3384 5334